Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Monte Rosa Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-28
Purchase
2021-06-30
6:09 pm
Monte Rosa Therapeutics Inc.GLUEYang Rick
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:08 pm
Monte Rosa Therapeutics Inc.GLUEWalker Paul Edward
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:08 pm
Monte Rosa Therapeutics Inc.GLUESonsini Peter W.
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:07 pm
Monte Rosa Therapeutics Inc.GLUESANDELL SCOTT D
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:06 pm
Monte Rosa Therapeutics Inc.GLUEMathers Edward T
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:06 pm
Monte Rosa Therapeutics Inc.GLUEMAKOWER JOSHUA
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:05 pm
Monte Rosa Therapeutics Inc.GLUEMakhzoumi Mohamad
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:04 pm
Monte Rosa Therapeutics Inc.GLUELandsman Liza
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:02 pm
Monte Rosa Therapeutics Inc.GLUEFlorence Anthony A. Jr.
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:02 pm
Monte Rosa Therapeutics Inc.GLUEChang Carmen
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:01 pm
Monte Rosa Therapeutics Inc.GLUEBehbahani Ali
Director
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
6:00 pm
Monte Rosa Therapeutics Inc.GLUEBASKETT FOREST
10% Owner
1,050,000$19$19,950,0007,692,298
(Indirect)
View
2021-06-28
Purchase
2021-06-30
5:59 pm
Monte Rosa Therapeutics Inc.GLUENew Enterprise Associates 17 L.P.
NEA Partners 17 L.P.
NEA 17 GP LLC
10% Owner
1,050,000$19$19,950,0007,692,298
(Direct)
View
2021-06-28
Purchase
2021-06-30
5:05 pm
Monte Rosa Therapeutics Inc.GLUEBolzon Bradley J PhD
Director
10% Owner
157,895$19$3,000,0052,097,938
(Indirect)
View
2021-06-28
Purchase
2021-06-30
5:00 pm
Monte Rosa Therapeutics Inc.GLUEVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
157,895$19$3,000,0058,897,053
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-03
Option Award
2023-01-04
4:31 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUEWallace Owen B.
Chief Scientific Officer
135,000$0135,000
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:31 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUEWarmuth Markus
President & CEO
472,000$0472,000
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:31 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUENickson Philip
General Counsel
123,650$0123,650
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:31 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUETownson Sharon
Chief Technology Officer
78,550$078,550
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:30 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUEJones Jullian G
Chief Business Officer
77,450$077,450
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:30 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUECastle John C.
Chief Data Scientist
78,500$078,500
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:30 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUETamboli Ajim
Chief Financial Officer
129,850$0129,850
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:30 pm
N/A
2033-01-02
Monte Rosa Therapeutics Inc.GLUEJanku Filip
Chief Medical Officer
135,000$0135,000
(Direct)
View
2022-12-15
Option Award
2022-12-19
4:42 pm
N/A
2032-10-02
Monte Rosa Therapeutics Inc.GLUEJanku Filip
Chief Medical Officer
36,000$036,000
(Direct)
View
2022-10-31
Option Award
2022-11-01
4:30 pm
N/A
2032-10-02
Monte Rosa Therapeutics Inc.GLUEJanku Filip
Chief Medical Officer
36,000$036,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
5:29 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUEBehbahani Ali
Director
10% Owner
15,000$015,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
4:32 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUESiu Christine
Director
15,000$015,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
4:31 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUESCHIFF ANDREW N
Director
15,000$015,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
4:30 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUEMayweg Alexander
Director
15,000$015,000
(Direct)
View
2022-06-15
Option Award
2022-06-16
4:30 pm
N/A
2032-06-14
Monte Rosa Therapeutics Inc.GLUEBlackwell Kimberly
Director
15,000$015,000
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:49 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUEJones Jullian G
Chief Business Officer
73,300$073,300
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:47 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUETamboli Ajim
Chief Financial Officer
111,700$0111,700
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:46 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUEJanku Filip
Chief Medical Officer
86,500$086,500
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:46 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUETownson Sharon
Chief Technology Officer
70,000$070,000
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:43 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUENickson Philip
General Counsel
70,600$070,600
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:42 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUECastle John C.
Chief Data Scientist
53,700$053,700
(Direct)
View
2022-03-01
Ownership
2022-03-02
6:39 pm
N/A
2031-05-16
Monte Rosa Therapeutics Inc.GLUENickson Philip
General Counsel
0$0116,120
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:32 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUEWallace Owen B.
Chief Scientific Officer
117,450$0117,450
(Direct)
View
2022-03-01
Option Award
2022-03-02
6:26 pm
N/A
2032-02-29
Monte Rosa Therapeutics Inc.GLUEWarmuth Markus
President & CEO
315,600$0315,600
(Direct)
View
2021-12-01
Ownership
2021-12-02
6:12 pm
N/A
2030-08-31
Monte Rosa Therapeutics Inc.GLUEJones Julian G
Chief Business Officer
0$0251,594
(Direct)
View
2021-06-28
Conversion
2021-06-30
6:09 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEYang Rick
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:08 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEWalker Paul Edward
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:08 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUESonsini Peter W.
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:07 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUESANDELL SCOTT D
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:06 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEMathers Edward T
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:06 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEMAKOWER JOSHUA
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:05 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEMakhzoumi Mohamad
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:04 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUELandsman Liza
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:02 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEFlorence Anthony A. Jr.
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:02 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEChang Carmen
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:01 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEBehbahani Ali
Director
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
6:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEBASKETT FOREST
10% Owner
30,092,935$07,692,298
(Indirect)
View
2021-06-28
Conversion
2021-06-30
5:59 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUENew Enterprise Associates 17 L.P.
NEA Partners 17 L.P.
NEA 17 GP LLC
10% Owner
30,092,935$07,692,298
(Direct)
View
2021-06-28
Conversion
2021-06-30
5:05 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEBolzon Bradley J PhD
Director
10% Owner
38,309,520$02,097,938
(Indirect)
View
2021-06-28
Conversion
2021-06-30
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc.GLUEVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
38,309,520$08,897,053
(Direct)
View
Goto 0, 1, Next